EP2305263
Stöðguð myndlaus form af imatíníbmesýlati
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
7.6.2007EP published:
19.9.2012EP application number:
10178116.9
EP translation filed:
26.9.2012Grant published:
15.10.2012EPO information:
European Patent Register
Max expiry date:
6.6.2027Expiry date:
6.6.2016
Title:
Stabilized amorphous forms of imatinib mesylate
Timeline
Today
7.6.2007EP application
19.9.2012EP Publication
26.9.2012Translation submitted
15.10.2012Registration published
6.6.2016Expires
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056, Basel, CH
Inventor
Name:
Goncalves, ElisabeteAddress:
Basel, CH
Name:
Kalb, OskarAddress:
Basel, CH
Name:
Mutz, MichaelAddress:
Freiburg, DE
Name:
Wirth, WolfgangAddress:
Arisdorf, CH
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
07109816Date:
7.6.2007Country:
EP
Classification
Categories:
A61K 31/506, A61K 9/16, A61P 35/02
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 4.4.2013
Expires: 6.6.2014
Payer: Sigurjónsson & Thor ehf.
Number: 8
Paid: 7.5.2014
Expires: 6.6.2015
Payer: Árnason Faktor
Number: 9
Paid: 7.5.2015
Expires: 6.6.2016
Payer: Árnason Faktor